Home/KM Biologics/Information not publicly prominent
IN

Information not publicly prominent

CEO

KM Biologics

Therapeutic Areas

KM Biologics Pipeline

DrugIndicationPhase
Tetanus and Diphtheria Toxoid VaccineProphylaxis against Tetanus and DiphtheriaApproved
Acellular Pertussis VaccineProphylaxis against PertussisApproved
Japanese Encephalitis VaccineProphylaxis against Japanese EncephalitisApproved
Rabies VaccinePost-exposure prophylaxis for RabiesApproved